2025 Q4 -tulosraportti
57 päivää sitten
‧13 min
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 3 100 | - | - | ||
| 54 833 | - | - | ||
| 921 | - | - | ||
| 20 202 | - | - | ||
| 63 371 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 176 280 | 1 176 280 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 176 280 | 1 176 280 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 12.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 12.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 12.5.2025 | ||
2024 Q4 -tulosraportti 13.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
18 t sitten18 t sittenDr. George Chrysant and I sat down with KOKH FOX 25 News, Oklahoma to discuss new research from the American Heart Association, and the implications are far bigger than many realize. By 2050, 6 in 10 U.S. women are projected to have some form of cardiovascular disease. At the same time, rates of diabetes and obesity in women are expected to rise by 67% and 36%, respectively. Even more concerning, cardiovascular disease is accelerating among younger populations, impacting nearly a third of women ages 20–44 and rising sharply among girls. This isn’t just a women’s health issue. It’s a public health issue that affects families, communities, and the future of our healthcare system. Despite being the leading cause of death for women, heart disease is still too often underdiagnosed, especially when symptoms don’t present in typical ways. That gap in awareness, detection, and access to care is something we must address now. At Acarix, we believe earlier insight leads to better outcomes. Advancing non-invasive, AI-driven diagnostics can play a critical role in identifying risk sooner, reducing unnecessary testing, and ultimately saving lives. This conversation is about more than statistics, it’s about changing the trajectory of cardiovascular health for everyone. Watch the segment below. #CardiovascularHealth #HeartHealth #WomensHealth #PreventiveCare #EarlyDetection Fox News Media Good Morning America
·1 päivä sittenSuper nice increase so far, when do people think we can hit 1 Swedish krona🥳🚀
1 päivä sitten1 päivä sitten
·1 päivä sitten"Oklahoma based Acaaaaarix has developed…" it's just funny But Aamir looks sharp, I think. Very good contribution. One has long had the feeling that it could become a snowball effect if it suddenly picks up speed seriously in more and more places·1 päivä sittenYes, I know that, but still comically superficial, US journalism where it - even in such a short segment - would require 3-5 seconds and a limited amount of words to weave in a phrase with a touch of depth. But that's fine, because it precisely benefits the case, which was the actual point. Love it. Because it would be great if one pushes hard and runs america first on the narrative, as that might open some doors faster.- ·2 päivää sittenI am really looking forward to Acarix living up to the expectations I have shared with family and friends, I must admit that I have gradually convinced quite a few in my circle. I remain optimistic, and my belief in the case has never been stronger. Especially the efforts in the usa look promising, Aamir seems to be doing a solid job of building relationships and strengthening the market position. I believe Aamir is preparing the relationships in the usa for a big Bullish. That being said, it wouldn't hurt if we could also hold on to the increases a bit more often. But after all, in the grand perspective, it is worth noting that the price is higher than a year ago. Good evening
- 29.3.29.3.CEO nyt fra LinkedIn: Great to spend time at #ACC with Ken Nelson, whose experience and perspective continue to be incredibly valuable as we scale Acarix in the U.S. and beyond. What stands out most is the convergence we are seeing across the ecosystem. Conversations with customers, partners, and industry leaders are no longer siloed. Commercial strategy, R&D innovation, and collaborative partnerships are aligning in a very real way. From a commercial standpoint, there is growing clarity around how #CADScor can be integrated into clinical workflows to drive better patient outcomes while reducing unnecessary testing. That alignment is critical as we continue to expand access and adoption. On the innovation side, our ongoing work in both CAD and heart failure is opening the door to a broader platform approach at the point of care. The ability to provide fast, actionable insights in minutes is resonating more than ever with clinicians and health systems. Equally important are the strategic discussions happening around collaboration.·29.3.Last part: Whether with providers, payors, or potential partners, there is a shared recognition that solving large scale healthcare challenges requires alignment, not fragmentation. We are building meaningful momentum, and it is being driven by the right conversations with the right people at the right time. Excited for what is ahead. #Acarix #HealthcareInnovation #Cardiology #PointOfCare #MedTech #Leadership
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
57 päivää sitten
‧13 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- 18 t sitten18 t sittenDr. George Chrysant and I sat down with KOKH FOX 25 News, Oklahoma to discuss new research from the American Heart Association, and the implications are far bigger than many realize. By 2050, 6 in 10 U.S. women are projected to have some form of cardiovascular disease. At the same time, rates of diabetes and obesity in women are expected to rise by 67% and 36%, respectively. Even more concerning, cardiovascular disease is accelerating among younger populations, impacting nearly a third of women ages 20–44 and rising sharply among girls. This isn’t just a women’s health issue. It’s a public health issue that affects families, communities, and the future of our healthcare system. Despite being the leading cause of death for women, heart disease is still too often underdiagnosed, especially when symptoms don’t present in typical ways. That gap in awareness, detection, and access to care is something we must address now. At Acarix, we believe earlier insight leads to better outcomes. Advancing non-invasive, AI-driven diagnostics can play a critical role in identifying risk sooner, reducing unnecessary testing, and ultimately saving lives. This conversation is about more than statistics, it’s about changing the trajectory of cardiovascular health for everyone. Watch the segment below. #CardiovascularHealth #HeartHealth #WomensHealth #PreventiveCare #EarlyDetection Fox News Media Good Morning America
- ·1 päivä sittenSuper nice increase so far, when do people think we can hit 1 Swedish krona🥳🚀
- 1 päivä sitten1 päivä sitten·1 päivä sitten"Oklahoma based Acaaaaarix has developed…" it's just funny But Aamir looks sharp, I think. Very good contribution. One has long had the feeling that it could become a snowball effect if it suddenly picks up speed seriously in more and more places·1 päivä sittenYes, I know that, but still comically superficial, US journalism where it - even in such a short segment - would require 3-5 seconds and a limited amount of words to weave in a phrase with a touch of depth. But that's fine, because it precisely benefits the case, which was the actual point. Love it. Because it would be great if one pushes hard and runs america first on the narrative, as that might open some doors faster.
- ·2 päivää sittenI am really looking forward to Acarix living up to the expectations I have shared with family and friends, I must admit that I have gradually convinced quite a few in my circle. I remain optimistic, and my belief in the case has never been stronger. Especially the efforts in the usa look promising, Aamir seems to be doing a solid job of building relationships and strengthening the market position. I believe Aamir is preparing the relationships in the usa for a big Bullish. That being said, it wouldn't hurt if we could also hold on to the increases a bit more often. But after all, in the grand perspective, it is worth noting that the price is higher than a year ago. Good evening
- 29.3.29.3.CEO nyt fra LinkedIn: Great to spend time at #ACC with Ken Nelson, whose experience and perspective continue to be incredibly valuable as we scale Acarix in the U.S. and beyond. What stands out most is the convergence we are seeing across the ecosystem. Conversations with customers, partners, and industry leaders are no longer siloed. Commercial strategy, R&D innovation, and collaborative partnerships are aligning in a very real way. From a commercial standpoint, there is growing clarity around how #CADScor can be integrated into clinical workflows to drive better patient outcomes while reducing unnecessary testing. That alignment is critical as we continue to expand access and adoption. On the innovation side, our ongoing work in both CAD and heart failure is opening the door to a broader platform approach at the point of care. The ability to provide fast, actionable insights in minutes is resonating more than ever with clinicians and health systems. Equally important are the strategic discussions happening around collaboration.·29.3.Last part: Whether with providers, payors, or potential partners, there is a shared recognition that solving large scale healthcare challenges requires alignment, not fragmentation. We are building meaningful momentum, and it is being driven by the right conversations with the right people at the right time. Excited for what is ahead. #Acarix #HealthcareInnovation #Cardiology #PointOfCare #MedTech #Leadership
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 3 100 | - | - | ||
| 54 833 | - | - | ||
| 921 | - | - | ||
| 20 202 | - | - | ||
| 63 371 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 176 280 | 1 176 280 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 176 280 | 1 176 280 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 12.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 12.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 12.5.2025 | ||
2024 Q4 -tulosraportti 13.2.2025 |
2025 Q4 -tulosraportti
57 päivää sitten
‧13 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 12.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 12.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 12.5.2025 | ||
2024 Q4 -tulosraportti 13.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- 18 t sitten18 t sittenDr. George Chrysant and I sat down with KOKH FOX 25 News, Oklahoma to discuss new research from the American Heart Association, and the implications are far bigger than many realize. By 2050, 6 in 10 U.S. women are projected to have some form of cardiovascular disease. At the same time, rates of diabetes and obesity in women are expected to rise by 67% and 36%, respectively. Even more concerning, cardiovascular disease is accelerating among younger populations, impacting nearly a third of women ages 20–44 and rising sharply among girls. This isn’t just a women’s health issue. It’s a public health issue that affects families, communities, and the future of our healthcare system. Despite being the leading cause of death for women, heart disease is still too often underdiagnosed, especially when symptoms don’t present in typical ways. That gap in awareness, detection, and access to care is something we must address now. At Acarix, we believe earlier insight leads to better outcomes. Advancing non-invasive, AI-driven diagnostics can play a critical role in identifying risk sooner, reducing unnecessary testing, and ultimately saving lives. This conversation is about more than statistics, it’s about changing the trajectory of cardiovascular health for everyone. Watch the segment below. #CardiovascularHealth #HeartHealth #WomensHealth #PreventiveCare #EarlyDetection Fox News Media Good Morning America
- ·1 päivä sittenSuper nice increase so far, when do people think we can hit 1 Swedish krona🥳🚀
- 1 päivä sitten1 päivä sitten·1 päivä sitten"Oklahoma based Acaaaaarix has developed…" it's just funny But Aamir looks sharp, I think. Very good contribution. One has long had the feeling that it could become a snowball effect if it suddenly picks up speed seriously in more and more places·1 päivä sittenYes, I know that, but still comically superficial, US journalism where it - even in such a short segment - would require 3-5 seconds and a limited amount of words to weave in a phrase with a touch of depth. But that's fine, because it precisely benefits the case, which was the actual point. Love it. Because it would be great if one pushes hard and runs america first on the narrative, as that might open some doors faster.
- ·2 päivää sittenI am really looking forward to Acarix living up to the expectations I have shared with family and friends, I must admit that I have gradually convinced quite a few in my circle. I remain optimistic, and my belief in the case has never been stronger. Especially the efforts in the usa look promising, Aamir seems to be doing a solid job of building relationships and strengthening the market position. I believe Aamir is preparing the relationships in the usa for a big Bullish. That being said, it wouldn't hurt if we could also hold on to the increases a bit more often. But after all, in the grand perspective, it is worth noting that the price is higher than a year ago. Good evening
- 29.3.29.3.CEO nyt fra LinkedIn: Great to spend time at #ACC with Ken Nelson, whose experience and perspective continue to be incredibly valuable as we scale Acarix in the U.S. and beyond. What stands out most is the convergence we are seeing across the ecosystem. Conversations with customers, partners, and industry leaders are no longer siloed. Commercial strategy, R&D innovation, and collaborative partnerships are aligning in a very real way. From a commercial standpoint, there is growing clarity around how #CADScor can be integrated into clinical workflows to drive better patient outcomes while reducing unnecessary testing. That alignment is critical as we continue to expand access and adoption. On the innovation side, our ongoing work in both CAD and heart failure is opening the door to a broader platform approach at the point of care. The ability to provide fast, actionable insights in minutes is resonating more than ever with clinicians and health systems. Equally important are the strategic discussions happening around collaboration.·29.3.Last part: Whether with providers, payors, or potential partners, there is a shared recognition that solving large scale healthcare challenges requires alignment, not fragmentation. We are building meaningful momentum, and it is being driven by the right conversations with the right people at the right time. Excited for what is ahead. #Acarix #HealthcareInnovation #Cardiology #PointOfCare #MedTech #Leadership
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 3 100 | - | - | ||
| 54 833 | - | - | ||
| 921 | - | - | ||
| 20 202 | - | - | ||
| 63 371 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 176 280 | 1 176 280 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 176 280 | 1 176 280 | 0 | 0 |